Lancer Orthodontics, Inc.
Lancer Orthodontics, Inc. (LANZ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lanz · pe ratio · data through May 31, 2004
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Lancer Orthodontics, Inc. (LANZ) measures how much investors pay for each dollar of the company's trailing earnings. LANZ's current PE ratio of 3.27x is calculated by dividing its stock price of $0.04 by its TTM earnings per share of $0.01. −84.9% discount vs 5Y avg 21.7x
Source: FMP · /ratios-ttm · /analyst-estimates · 2004-05-31
PE Ratio History
1992 – 2004 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 9 fiscal years · Front-end computedMinQ1 · 25%15.6x
MedianQ3 · 75%60.5x
Max
At 3.27x, LANZ's current P/E is lower than in 0% of its annual fiscal year readings over the past 9 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Lancer Orthodontics, Inc.You LANZ | $0M | 3.27x | — | $0.01 |
 Better Therapeutics, Inc. BTTX | $0M | N/A | — | -$1.69 |
 InnerScope Hearing Technologies, Inc. INND | $0M | N/A | — | -$0.00 |
 Inyx, Inc. IYXI | $0M | N/A | — | -$0.78 |
 MJ Holdings, Inc. MJNE | $0M | N/A | — | -$0.07 |
 MedSmart Group Inc. MSGP | $0M | N/A | — | -$0.00 |
 Oncology Pharma Inc. ONPH | $2M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2004-05-31Latest FY2004 | 60.47x | $0.01 | +363.4% | |
2003-05-31 FY2003 | 13.05x | $0.03 | -25.4% | |
2002-05-31 FY2002 | 17.50x | $0.02 | — | |
2001-05-31 FY2001 | — | $-0.06 | — | |
2000-05-31 FY2000 | — | $-0.15 | — | |
1999-05-31 FY1999 | — | $0.00 | — | |
1998-05-31 FY1998 | 10.42x | $0.12 | +50.9% | |
1997-05-31 FY1997 | 6.90x | $0.09 | -55.9% | |
1996-05-31 FY1996 | 15.64x | $0.14 | +71.5% | |
1995-05-31 FY1995 | 9.12x | $0.10 | -42.3% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Lancer Orthodontics, Inc. (LANZ) measures how much investors pay for each dollar of the company's trailing earnings. LANZ's current PE ratio of 3.27x is calculated by dividing its stock price of $0.04 by its TTM earnings per share of $0.01.
Frequently asked questions
LANZ pe ratio · 6 questionsLANZ's current PE ratio is 3.27x as of 2026-06-09, based on a stock price of $0.04 and TTM EPS of $0.01. Data sourced from Financial Modeling Prep via LANZ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lancer Orthodontics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09